An open-label cluster-randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID-19 (ARCHAIC)-Protocol publication.

Weehuizen, Jesper M; Hoepelman, Andy I M

Weehuizen, Jesper M; Hoepelman, Andy I M.

Weehuizen JM; Department of Infectious Diseases, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
Hoepelman AIM; Department of Infectious Diseases, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.

Eur J Clin Invest ; 50(7): e13297, 2020 Jul.

Article in English | MEDLINE | ID: covidwho-436647

Subject(s)

Antiviral Agents/therapeutic use; Chloroquine/therapeutic use; Coronavirus Infections/drug therapy; Hydroxychloroquine/therapeutic use; Pneumonia, Viral/drug therapy; Betacoronavirus; COVID-19; Electrocardiography; Hospitalization; Humans; Long QT Syndrome/chemically induced; Long QT Syndrome/physiopathology; Netherlands; Pandemics; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pneumonia, Viral / Chloroquine / Coronavirus Infections / Hydroxychloroquine Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Limits: Humans Country/Region as subject: Europa Language: English Journal: Eur J Clin Invest Year: 2020 Document Type: Article Affiliation country: Eci.13297

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google